Antidepressant-like effect of etazolate, a cyclic nucleotide phosphodiesterase 4 inhibitor - An approach using rodent behavioral antidepressant tests battery

European Journal of Pharmacology

Volumn 689, Issue 1-3, 2012, Pages 125-131

  Jindal, Ankur ^a   Mahesh, Radhakrishnan ^a   Gautam, Baldev ^a   Bhatt, Shvetank ^a   Pandey, Dilip ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Animal models; Antidepressant; cAMP; Depression; Etazolate; Phosphodiesterase 4

Indexed keywords

DESIPRAMINE; ETAZOLATE; FLUOXETINE; RESERPINE; VENLAFAXINE;

ACTOPHOTOMETER; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; EXPERIMENTAL TEST; FORCED SWIMMING TEST; HEAD TWITCH; LOCOMOTION; MALE; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD TEST; PHOTOMETER; PRIORITY JOURNAL; RAT; TAIL SUSPENSION TEST;

ANIMALS; ANTIDEPRESSIVE AGENTS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; ETAZOLATE; MALE; MICE; PHOSPHODIESTERASE 4 INHIBITORS; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 84864285338     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.05.051     Document Type: Article

References (62)

1. M. aan het Rot, K.A. Collins, and H.L. Fitterling Physical exercise and depression Mt. Sinai J. Med. 76 2009 204 214
2. B.M. Askew A simple screening procedure for imipramine-like antidepressant agents Life. Sci. 2 1963 725 730
3. T.C. Baghai, H.J. Möller, and R. Rupprecht Recent progress in pharmacological and non-pharmacological treatment options of major depression Curr. Pharm. Dev. 12 2006 503 515
4. J.A. Beavo Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms Physiol. Rev. 75 1995 725 748
5. B. Beer, M. Chasin, D.E. Clody, and J.R. Vogel Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety Science 176 1972 428 430
6. O. Berton, and E.J. Nestler New approaches to antidepressant drug discovery: beyond monoamines Nat. Rev. Neurosci. 7 2006 137 151 (Pubitemid 43151600)
7. D. Bobon, D.M. Breulet, M.A. Gerard-Vandenhove, F. GuiotGoffioul, M. Sastre-y-Hernández, M. Schratzer, B. Troisfontaines, Frenckell von, and R. Wachtel, H. Is Phosphodiesterase inhibition a new mechanism of antidepressant action Eur. Arch. Psychiatry Neurol. Sci. 238 1988 2 6
8. J.R. Boissier, and P. Simon Action of caffeine on the spontaneous motility of the mouse Arch. Int. Pharmacodyn. Ther. 158 1965 212 221
9. M. Bourin, F. Chenu, N. Ripoll, and D.J.P. David A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests Behav. Brain Res. 164 2005 266 269 (Pubitemid 41337881)
10. M. Bourin, A.J. Fiocco, and F. Clenet How valuable are animal models in defining antidepressant activity? Hum. Psychopharmacol. Clin. Exp. 16 2001 9 21
11. K.D. Cairncross, B. Cox, C. Forster, and A.F. Wren Olfactory projection systems, drugs and behaviour: a review Psychoneuroendocrinology 4 1979 253 272 (Pubitemid 10209956)
12. M. Conti, G. Nemoz, C. Sette, and E. Vicini Recent progress in understanding the hormonal regulation of phosphodiesterases Endocr. Rev. 16 1995 370 389
13. J.F. Cryan, A. Markou, and I. Lucki Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol. Sci. 23 2002 238 245 (Pubitemid 34465544)
14. J.F. Cryan, R.J. Valentinom, and I. Lucki Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test Neurosci. Biobehav. Rev. 9 2005 547 569 (Pubitemid 40755456)
15. K. Demyttenaere Compliance during treatment with antidepressants J. Affect. Disord. 43 1997 27 39 (Pubitemid 27146246)
16. T. Devadoss, D.K. Pandey, R. Mahesh, and S.K. Yadav Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression Pharmacol. Rep. 62 2010 245 257
17. D. Dlaboga, H. Hajjhussein, and J.M. O'Donnell Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram Brain Res. 1096 2006 104 112 (Pubitemid 43928922)
18. J. Drott, L. Desire, D. Drouin, M. Pando, and F. Haun Etazolate improves performance in a foraging and homing task in aged rats Eur. J. Pharmacol. 634 2010 95 100
19. W.W. Fleischhacker, H. Hinterhuber, H. Bauer, B. Pflug, P. Berner, C. Simhandl, R. Wilf, W. Gerlach, H. Jaklitsch, M. Sastrey-Hernandez, H. Schmeding-Wiegel, B. Sperner-Unter-weger, B. Voet, and H. Schubert A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder Neuropsychobiology 26 1992 59 64
20. K. Fujimaki, S. Morinobu, and R.S. Duman Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus Neuropsychopharmacology 22 2000 42 51
21. M.F. Grunebaum, H.C. Galfalvy, M.A. Oquendo, A.K. Burke, and J.J. Mann Melancholia and the probability and lethality of suicide attempts Br. J. Psychiatry 184 2004 534 535 (Pubitemid 38725714)
22. G. Guadarrama-Cruz, F.J. Alarcon-Aguilar, R. Lezama-Velasco, G. Vazquez-Palacios, and H. Bonilla-Jaime Antidepressant-like effects of Tagetes lucida Cav. in the forced swimming test J. Ethnopharmacol. 120 2008 277 281
23. T.B. Halene, and S.J. Siegel PDE inhibitors in psychiatry - future options for dementia, depression and schizophrenia Drug Discov. Today 12 2007 870 878 (Pubitemid 47539966)
24. Z.P. Horovitz, B. Beer, D.E. Clody, J.R. Vogel, and M. Chasin Cyclic AMP and anxiety Psychomatics 13 1972 85 92
25. M.D. Houslay PDE4 cAMP-specific phosphodiesterases Prog. Nucleic Acid Res. Mol. Biol. 69 2001 249 315 (Pubitemid 33805840)
26. J.P. Kelly, and B.E. Leonard The effect of tianeptine and sertraline in three animal models of depression Neuropharmacology 33 1994 1011 1016 (Pubitemid 24290529)
27. J.P. Kelly, A.S. Wyrnn, and B.E. Leonard Olfactory bulbectomized rat as a model of depression: an update Pharmacol. Ther. 74 1997 299 316 (Pubitemid 27425352)
28. I. Lucki The forced swimming test as a model for core and component behavioral effects of antidepressant drugs Behav. Pharmacol. 8 1997 523 532 (Pubitemid 27504702)
29. M. Maes, R. Yirmyia, J. Noraberg, S. Brene, J. Hibbeln, G. Perini, M. Kubera, P. Bob, B. Lerer, and M. Maj The inflammatory and neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression Metab. Brain Dis. 24 2009 27 53
30. R. Mahesh, A. Jindal, B. Gautam, S. Bhatt, and D. Pandey Evaluation of anti-depressant-like activity of linezolid, an oxazolidinone class derivative - an investigation using behavioral tests battery of depression Biochem. Biophys. Res. Commun. 409 2011 723 726
31. R. Mahesh, R. Rajkumar, B. Minasri, and R. Venkatesha Perumal Potential antidepressants: pharmacology of 2-(4-methylpiperazin-1-yl)-1,8-naphthyridine- 3carbonitrile in rodent behavioral models Pharmazie 62 2007 919 924 (Pubitemid 350305768)
32. H.K. Manji, and R.S. Duman Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics Psychopharmacol. Bull. 35 2001 5 49
33. P. Martin, J. Massol, P. Soubrie, and A.J. Puech Effects of triiodothyronine (T3) on the potentiation by anti-depressants of L-5-hydroxytryptophan-induced head twitches in mice Prog. Neuropsychopharmacol. Biol. Psychiatry 13 1989 735 748 (Pubitemid 19218036)
34. C.B. Nemeroff The burden of severe depression: a review of diagnostic challenges and treatment alternatives J. Psychiatr. Res. 41 2007 189 206 (Pubitemid 44854991)
35. J.M. O'Donnell, and H.T. Zhang Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4) Trends Pharmacol. Sci. 25 2004 158 163 (Pubitemid 38264507)
36. P. Pacher, E. Kohegyi, V. Kecskemeti, and S. Furst Current trends in the development of new antidepressants Curr. Med. Chem. 8 2001 89 100 (Pubitemid 32409768)
37. D.K. Pandey, R. Rajkumar, R. Mahesh, and R. Radha Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery J. Pharm. Pharmacol. 60 2008 1643 1650
38. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioural despair in mice: a primary screening test for anti-depressants Arch. Int. Pharmacodyn. Ther. 229 1977 327 336 (Pubitemid 8225714)
39. R. Rajkumar, and R. Mahesh Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models Curr. Neuropharmacol. 6 2008 215 234
40. R. Rajkumar, D.K. Pandey, R. Mahesh, and R. Radha 1-(m-Chlorophenyl) piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay Eur. J. Pharmacol. 608 2009 32 41
41. R. Ramamoorthy, M. Radhkrishnan, and M. Borah Anti-depressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models Behav. Pharmacol. 19 2008 29 40
42. J.P. Redrobe, and M. Bourin Partial role of 5-HT2 and 5-HT receptors in the activity of antidepressants in the mouse forced swimming test Eur. J. Pharmacol 325 1997 129 135 (Pubitemid 27199561)
43. H.G. Ruhé, J. Huyser, J.A. Swinkels, and A.H. Schene Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review J. Clin. Psychiatry 67 2006 1836 1855 (Pubitemid 46055194)
44. L. Santarelli, M. Saxe, C. Gross, A. Surget, F. Battaglia, and S. Dulawa Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809 (Pubitemid 36962615)
45. T. Sasaki, K. Kitagawa, E. Omura-Matsuoka, K. Todo, Y. Terasaki, S. Sugiura, J. Hatazawa, Y. Yagita, and M. Hori The phosphodiesterase inhibitor rolipram promotes survival of newborn hippocampal neurons after ischemia Stroke 38 2007 1597 1605 (Pubitemid 46684180)
46. H.H. Schneider, R. Schmiechen, M. Brezinski, and J. Seidler Stereospecific binding of the antidepressant rolipram to brain protein structures Eur. J. Pharmacol. 127 1986 105 115 (Pubitemid 16023615)
47. J. Scuvee-Moreau, I. Giesbers, and A. Dreese Effect of rolipram, a phosphodiesterase inhibitor and potential antidepressant, on the firing rate of central monoaminerigic neurons in the rat Arch. Int. Pharmacodyn. Ther. 288 1987 43 49 (Pubitemid 17134785)
48. R.C. Shelton, D.H. Mainer, and F. Sulser cAMP-dependent protein kinase activity in major depression Am. J. Psychiatry 153 1996 1037 1042 (Pubitemid 26264704)
49. T.A. Slotkin, M.M. Cousins, C.A. Tate, and F.J. Seidler Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs. aging rats Neuropsychopharmacology 30 2005 52 57 (Pubitemid 40024399)
50. C. Song, and B.E. Leonard The olfactory bulbectomised rat as a model of depression Neurosci. Biobehav. Rev. 29 2005 627 647 (Pubitemid 40755458)
51. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening anti-depressant drugs Psychopharmacolgy (Berlin) 85 1985 367 370 (Pubitemid 15123115)
52. S.N. Umathe, P.S. Bhutada, N.S. Jain, N.R. Shukla, Y.R. Mundhada, and P.V. Dixit Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice Neuropeptides 42 2008 399 410
53. H.M. Van der Stelt, M.E. Breuer, B. Olivier, and H.G. Westenberg Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study Biol. Psychiatry 57 2005 1061 1067 (Pubitemid 40603089)
54. H. Van Riezen, and A. Delver The effect of a number of drugs with different pharmacological properties upon reserpine induced hypothermia in mice Arzneimittelforschung 21 1971 1562 1566
55. H. Van Reizen, and B.E. Leonard Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory bulbectomized rats Pharmacol. Ther. 47 1990 21 34 (Pubitemid 20183306)
56. H. Wachtel Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors Psychopharmacology 77 1982 309 316 (Pubitemid 12061692)
57. H. Wachtel Dysbalance of neuronal second messenger function in the etiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors J. Neural Transm. 75 1989 21 29 (Pubitemid 19027068)
58. H. Wachtel, and H.H. Schneider Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoaminereceptors Neuropharmacology 25 1986 1119 1126 (Pubitemid 16010226)
59. P. Wang, J.G. Myers, P. Wu, B. Cheewatrakoolpong, R.W. Egan, and M.M. Billah Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D Biochem. Biophys. Res. Commun. 234 1997 320 324 (Pubitemid 27243900)
60. J.M. Wierońska, M. Papp, and A. Pilc Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats Pol. J. Pharmacol. 53 2001 517 525 (Pubitemid 33138837)
61. H.T. Zhang, Y. Huang, S.L. Jin, S.A. Frith, N. Suvarna, M. Conti, and J.M. O'Donnell Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme Neuropsychopharmacology 27 2002 587 595
62. Y. Zhao, H.T. Zhang, and J.M. O'Donnell Antidepressant-induced increase in high-affinity Rolipram binding sites in rat brain: dependence on noradrenergic and serotonergic function J. Pharmacol. Exp. Ther. 307 2003 246 253 (Pubitemid 37151914)